With the annual 340B hospital recertification period occurring Aug. 12 to Sept. 9, the Health Resources and Services Administration’s (HRSA’s) [...] …
Blog Posts
SPONSORED CONTENT
The 340B program is designed to help healthcare providers serving vulnerable populations stretch scarce resources as far as possible. In the face of increasing manufacturer restrictions, it is crucial for safety-net providers to explore various strategies to maintain financial sustainability. One of the
…
The Senate panel responsible for federal appropriations legislation overwhelmingly passed a bill last week that would increase funding for the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novartis is now the third drug manufacturer to challenge Kansas’ new law prohibiting drug manufacturers from restricting contract pharmacy access [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A long-awaited bipartisan senate bill to overhaul the 340B program will not be introduced prior to the August Congressional recess [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. government is urging a federal appeals court to dismiss a lower court’s “erroneous” decision to dismiss a California [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Missouri’s new 340B contract pharmacy access law is getting increased attention in state primary races just days before voters head [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A powerful drug industry trade group has asked the U.S. Supreme Court to overturn a federal appeals court’s decision to [...] …